Repligen Corporation to Present at Upcoming Investor Conferences

Rhea-AI Summary

Repligen Corporation (NASDAQ:RGEN) announced its participation in two investor conferences. The first is Stifel’s 2021 Virtual Healthcare Conference from November 15-17, where CEO Tony J. Hunt will hold a fireside chat on November 17 at 8:00 a.m. EST. The second is the Stephens Annual Investment Conference from December 1-3, featuring CFO Jon K. Snodgres on December 3 at 11:00 a.m. EST. Live webcasts will be accessible through the Investor Relations section of the company’s website, with replays available thereafter.

WALTHAM, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at two upcoming investor conferences.

• Stifel’s 2021 Virtual Healthcare Conference being held November 15-17. Tony J. Hunt, President and Chief Executive Officer, will participate in a fireside chat on Wednesday, November 17, at 8:00 a.m. EST.
• Stephens Annual Investment Conference being held December 1-3. Jon K. Snodgres, Chief Financial Officer, will participate in a fireside chat on Friday, December 3, at 11:00 a.m. EST.
  

A live webcast of the discussions will be accessible through the Investor Relations section of the Company’s website, and will be available for replay for a limited period of time following the conference event.

About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. We are inspiring advances in bioprocessing for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of our manufacturing sites are located within the U.S. (California, Massachusetts, New Hampshire, New Jersey and New York), and outside of the U.S. we have sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the company, including Repligen news releases, see our website at www.repligen.com. Follow us on LinkedIn and Twitter

Repligen Contact:
Sondra S. Newman
Global Head of Investor Relations
(781) 419-1881
investors@repligen.com

 

FAQ

What are the dates of Repligen's upcoming investor conferences in November 2021?

Repligen's upcoming investor conference, Stifel’s 2021 Virtual Healthcare Conference, is from November 15-17, 2021.

When will the CEO of Repligen speak at the Stifel conference?

Tony J. Hunt, the CEO of Repligen, will participate in a fireside chat on November 17, 2021, at 8:00 a.m. EST.

What is the schedule for the Stephens Annual Investment Conference for Repligen?

At the Stephens Annual Investment Conference, CFO Jon K. Snodgres will speak on December 3, 2021, at 11:00 a.m. EST.

Where can I find the live webcast of Repligen's investor conference presentations?

The live webcast of Repligen's presentations will be available in the Investor Relations section of their website.

Will Repligen's investor conference presentations be available for replay?

Yes, Repligen's investor conference presentations will be available for replay for a limited time after the events.